Psilocybin is not legal in Mexico for general use. Mexico’s federal health law classifies psilocybin and psilocin as prohibited Group I substances, and the only clear exemption protects indigenous communities using mushrooms in established ceremonies. Everyone else, including tourists at the retreats that have multiplied across Oaxaca and other southern states, faces real criminal exposure for possession, cultivation, or distribution. A 2009 reform decriminalized small personal quantities of several drugs, but psilocybin was left without a defined threshold, which leaves the practical answer messier than the statute suggests.
What the General Health Law Actually Bans
The Ley General de Salud is the controlling statute. Article 245 places psilocybin and psilocin in Group I, the category reserved for substances the government considers to have no therapeutic value and a high risk to public health. Article 247 goes further than banning the compounds themselves. It prohibits every link in the chain: growing, harvesting, preparing, buying, possessing, and consuming Group I substances.1Justia Mexico. Ley General de Salud Titulo Decimo Segundo Capitulo VI The classification specifically names Psilocybe mexicana and Psilocybe cubensis, so the prohibition reaches the fungi themselves, not only the isolated chemicals.
One narrow carve-out at the government level: wild-growing Psilocybe mushrooms are not treated as drug production. A field of naturally occurring mushrooms is not a drug lab. That distinction matters in regions where the species grow abundantly, but it creates no legal right to pick, carry, or consume them.
The Indigenous Ceremonial Exemption
The broadest legal shield for psilocybin use in Mexico belongs to indigenous peoples practicing established ceremonial traditions. Article 2 of the Mexican Constitution recognizes the right of indigenous communities to preserve their culture, knowledge, and institutional practices.2Constitute. Mexico 1917 (rev. 2015) Constitution Article 195 bis of the Federal Penal Code gives that mandate teeth by providing that ceremonial use of psilocybin mushrooms and peyote within indigenous communities is not subject to criminal prosecution.3WIPO Lex. Federal Criminal Code
The protection turns on “usos y costumbres” (uses and customs). The ceremony must be rooted in the established spiritual or medicinal traditions of a recognized indigenous group, not an improvised ritual organized for outsiders. Enforcement tends to be permissive in places like the Mazatec highlands of Oaxaca, where mushroom ceremonies have deep historical roots.
The limit matters more than the exemption itself. Article 195 bis does not extend to non-indigenous Mexicans, to tourists, or to self-described shamans running commercial retreats. A foreigner participating in a ceremony led by an indigenous healer sits in legally ambiguous territory. The healer may be protected under the exemption; the participant almost certainly is not.
Personal Possession After the 2009 Reform
Mexico’s 2009 “Narcomenudeo” reform reshaped how the country handles small-scale drug possession. The law created a table of maximum doses for personal and immediate consumption, with specific weight thresholds for several substances: 5 grams for marijuana, 0.5 grams for cocaine, 50 milligrams for heroin, 40 milligrams for methamphetamine, and 0.015 milligrams for LSD. Psilocybin does not appear on the table with a defined limit.
When someone is caught with an amount at or below a listed threshold, prosecutors cannot bring criminal charges. The individual receives a notation that no criminal action was taken and is released. A third apprehension triggers mandatory referral to a drug treatment program, still with no jail time.
The absence of a specific psilocybin threshold is where most casual users get into trouble. Without a defined weight, police and prosecutors decide for themselves whether a given amount qualifies as personal use. In practice, very small quantities of dried mushrooms are sometimes handled under the personal-use framework, but nothing in the statute guarantees it. There is no bright line to stay behind.
Even when authorities ultimately decline to prosecute, the encounter is not consequence-free. Police can detain you and transport you to the Public Ministry, which has up to 48 hours to investigate and decide whether to file charges. During that window, you are held as a suspect.
Criminal Penalties If You’re Charged
Once quantities exceed anything that could plausibly be called personal use, the Federal Penal Code imposes steep penalties structured by intent.
- Production, transport, trafficking, or distribution without authorization carries 10 to 25 years in prison and a fine of 100 to 500 days under Article 194.3WIPO Lex. Federal Criminal Code
- Possession with the purpose of engaging in those activities carries 5 to 15 years in prison and a fine of 100 to 350 days under Article 195.3WIPO Lex. Federal Criminal Code
- Possession where the circumstances show no trafficking intent drops to 4 to 7.5 years in prison and a fine of 50 to 150 days under Article 195 bis.3WIPO Lex. Federal Criminal Code
The line between “intent to traffic” and “no intent to traffic” is usually drawn from circumstantial evidence: scales, baggies, large cash amounts, or multiple individually wrapped portions. Prosecutors regularly use that evidence to push charges from the lower tier into the higher one.
What This Means for Tourists and Retreat Participants
Mexico’s psychedelic retreat industry operates in a grey zone that is far less protected than marketing materials suggest. Article 195 bis was written for recognized indigenous communities practicing ancestral traditions, not for commercial operations catering to foreigners. A retreat run by a non-indigenous facilitator has no legal basis for providing psilocybin to participants, however the ceremony is framed.
If you are caught with mushrooms, you face the same criminal exposure as anyone else under Mexican law. Without a defined personal-use threshold for psilocybin, even small amounts leave you at the mercy of prosecutorial discretion. Detention, transfer to the Public Ministry, and a 48-hour investigative hold are all possible even if charges are not ultimately filed. An arrest also creates records that can follow you home. For U.S. residents, any foreign drug offense can affect visa eligibility and immigration status.
Facilitators carry their own exposure. Authorities have arrested people transporting psychedelic substances, and border agents actively target drug trafficking. The relative rarity of enforcement against small-scale ceremonial use does not make that use legal. Confusing rare enforcement with legality is the single most common mistake people make when planning these trips.
Spores and Grow Kits
Psilocybin mushroom spores do not themselves contain psilocybin or psilocin. Because the General Health Law targets the psychoactive compounds and the mature fungi that produce them, spores fall outside the prohibition. Spore syringes and grow kits are sold openly online within Mexico. The legal risk begins the moment those spores germinate into mushrooms that produce psilocybin. Possession of the growing fungi then triggers the same prohibitions as possession of dried mushrooms. The line is technically clear and practically razor-thin.
Medical and Therapeutic Access
There is no approved therapeutic psilocybin program in Mexico, and no administrative process by which an individual can obtain a personal-use permit. Legitimate research involving psilocybin requires approval from COFEPRIS, the Federal Commission for Protection against Sanitary Risks, which acts as the gatekeeper for clinical studies involving controlled substances.4ClinRegs. Clinical Research Regulation For Mexico Any institution handling Group I substances must obtain specific permits, pass facility inspections, meet storage-security requirements, and submit detailed human-trial protocols. In practice, only accredited universities and established medical facilities have the resources to qualify. Despite rising global interest in psilocybin-assisted therapy, Mexico’s regulatory framework has not loosened, and nothing in the current legal structure suggests an approved therapeutic program is imminent.